{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:45:05Z","timestamp":1787024705070,"version":"build-2736575974"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7691-26","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:10:12Z","timestamp":1783721412000},"source":"Crossref","is-referenced-by-count":1,"title":["New-onset Systemic Lupus Erythematosus after Methimazole Exposure Followed by Autoantibody Emergence"],"prefix":"10.2169","author":[{"given":"Ayaka","family":"Ishida","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Asano","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuma","family":"Okada","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Sugishita","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kawataka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kido","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hounoki","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kato","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet 403: 2326-2338, 2024.","DOI":"10.1016\/S0140-6736(24)00398-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Katz U, Zandman-Goddard G. Drug-induced lupus: an update. Autoimmun Rev 10: 46-50, 2010.","DOI":"10.1016\/j.autrev.2010.07.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mei X, Li Y, Qiu P, Tang MW, Lan T. Anti-thyroid drug-induced lupus: a case report and review of the literature. Arch Endocrinol Metab 60: 290-293, 2015.","DOI":"10.1590\/2359-3997000000113"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fletcher K, Johnson DB. Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update. J Immunother Cancer 12: e008591, 2024.","DOI":"10.1136\/jitc-2023-008591"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Deeb N, Deeb S, Badawi M, Alfrookh M, Douden B, Atawnah SI. Rapid-onset methimazole-induced lupus in a pediatric patient with Graves' disease: a case report and review of the literature. Front Pediatr 13: 1687328, 2025.","DOI":"10.3389\/fped.2025.1687328"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Beernaert L, Vanderhulst J. Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency. Am J Case Rep 21: e927929, 2020.","DOI":"10.12659\/AJCR.927929"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Seo JY, Byun HJ, Cho KH, Lee EB. Methimazole-induced bullous systemic lupus erythematosus: a case report. J Korean Med Sci 27: 818-821, 2012.","DOI":"10.3346\/jkms.2012.27.7.818"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533, 2003.","DOI":"10.1056\/NEJMoa021933"},{"key":"9","unstructured":"9. Petri M, Orbai AM, Alarc\u00f3n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64: 2677-2686, 2012."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Suppiah R, Robson JC, Grayson PC, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis 81: 321-326, 2022.","DOI":"10.1002\/art.41983"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Robson JC, Grayson PC, Ponte C, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis. Ann Rheum Dis 81: 315-320, 2022.","DOI":"10.1002\/art.41986"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124-131, 2007.","DOI":"10.1002\/pbc.21039"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dalle Vedove C, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res. 301: 99-105, 2009.","DOI":"10.1007\/s00403-008-0895-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haq I, Sosin MD, Wharton S, Gupta A. Carbimazole-induced lupus. BMJ Case Rep. 2013: 2013.","DOI":"10.1136\/bcr-2012-007596"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takaya K, Kimura N, Hiyoshi T. Antithyroid Arthritis Syndrome: A Case Report and Review of the Literature. Intern Med 55: 3627-3633, 2016.","DOI":"10.2169\/internalmedicine.55.7379"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Yang S, Zhou J. Systemic lupus erythematosus and antineutrocytic cytoplasmic antibody-associated vasculitis overlap syndrome presenting mainly with alveolar hemorrhage: A case report and literature review. Medicine 102: e36356, 2023.","DOI":"10.1097\/MD.0000000000036356"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Fousert E, Toes R, Desai J. Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses. Cells 9: 915, 2020.","DOI":"10.3390\/cells9040915"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wigerblad G, Kaplan MJ. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat Rev Immunol. 23: 274-288, 2023.","DOI":"10.1038\/s41577-022-00787-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Enocsson H, Sj\u00f6wall C, Skogh T, Eloranta ML, R\u00f6nnblom L, Wetter\u00f6 J. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?. Arthritis Rheum. 60: 3755-3760, 2009.","DOI":"10.1002\/art.25042"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakazawa D, Masuda S, Tomaru U, Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol 15: 91-101, 2019.","DOI":"10.1038\/s41584-018-0145-y"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Deane JA, Pisitkun P, Barrett RS, et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810, 2007.","DOI":"10.1016\/j.immuni.2007.09.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Giordano D, Kuley R, Draves KE, Elkon KB, Giltiay NV, Clark EA. B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease. Front Immunol 14: 1050528, 2023.","DOI":"10.3389\/fimmu.2023.1050528"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7691-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:32:45Z","timestamp":1783740765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7691-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7691-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7691-26"}}